Delivery Order 75F40119D10032-75F40121F19004

Award Date 9/10/21
Potential Completion Date 10/10/24
Potential Value $1.4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Bend, WI 53095, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the U.S. Food and Drug Administration (FDA) to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $5,454,071.53 contract is for the provision of clinical and laboratory applied regulatory science services to support the FDA's regulatory science programs and assist with regulatory decision-making across product lifecycles. The services include conducting clinical pharmacology studies, QT prolongation...
This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical...
The U.S. Food and Drug Administration (FDA) awarded a $6,000,320.69 firm fixed price delivery order contract to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business, for-profit organization, and limited liability company. The contract is for clinical pharmacology studies to support the FDA's regulatory science programs and assist in regulatory decision-making across product lifecycles. Spaulding Clinical Research performs this work at its facilities in West Bend,...
This is a $17,112.06 Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business. The order is for services to maintain, repair, and certify specialized laboratory equipment and infrastructure at the FDA's White Oak Campus in Silver Spring, Maryland. This delivery order is part of two larger indefinite delivery vehicles (IDVs) that Laboratory Equipment Service holds with the FDA, valued at...
The U.S. Food and Drug Administration (FDA) awarded a $4,318.13 firm fixed price delivery order to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, to provide maintenance and repair services for specialized equipment at the FDA's White Oak Campus in Silver Spring, Maryland. This delivery order is part of a larger $50 million single-award indefinite delivery vehicle (IDV) contract that the FDA awarded to Laboratory Equipment Service in September 2022 to support...
This is a delivery order awarded by the U.S. Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, for $4,544.30. The contract is for troubleshooting and repairs to the power distribution unit (PDU) wiring in Building 2, Room 0301 at the FDA's facility in Calverton, Maryland. This work supports the FDA's laboratory operations and infrastructure, which enables the agency to carry out its regulatory and public health mission of...
This is a firm fixed-price delivery order awarded by the U.S. Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business. The order, valued at $13,235.41, is for the provision of "above standard equipment" services at the FDA's White Oak Campus in Silver Spring, Maryland. The services include air balance testing, as well as the maintenance, repair, and certification of specialized laboratory equipment and infrastructure that...
This is a $13,342.94 firm fixed-price delivery order awarded by the U.S. Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a small disadvantaged business. The order is for services to install 2 REES probes and perform other above-standard equipment installation and maintenance work at the FDA's Building 5272, Room 1138 facility. This delivery order is funded through one of Laboratory Equipment Service's two existing indefinite delivery vehicles (IDVs) with the FDA, which...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, for electrical work at the FDA's White Oak Campus, Building 5272, Rooms G116-G118. The order is valued at $6,824.75 and has a completion date of July 31, 2025. This order is part of a larger $50 million single-award indefinite delivery vehicle (IDV) that is 100% set aside for small businesses, awarded to Laboratory...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Laboratory Equipment Service, LLC, a self-certified small disadvantaged business, for $408,118.40. The contract is for services related to providing above-standard equipment for Building 72 site scan services. The contract has an ultimate completion date of March 31, 2027. This order is part of two larger indefinite delivery vehicle (IDV) contracts the vendor holds with the FDA, one valued...
  • 75F40119D10032
    Indefinite Delivery Contract
  • 75F40119D10032-75F40121F19004
    Delivery Order

This $1,429,138.43 firm fixed price delivery order was awarded to Spaulding Clinical Research, LLC by the Food and Drug Administration (FDA), a civilian agency of the U.S. government. The delivery order was issued under Spaulding's $30 million Indefinite Delivery Indefinite Quantity (IDIQ) contract with the FDA for clinical and laboratory applied regulatory science services.

The delivery order is for clinical electrocardiogram (ECG) studies to evaluate the electrophysiological effects of potential QT prolonging drugs using novel ECG biomarkers. This work supports the FDA's regulatory science programs and assists in regulatory decision-making across product lifecycles. Spaulding will perform the ECG studies at its facilities in West Bend, Wisconsin and Silver Spring, Maryland, with an ultimate completion date of October 10, 2024. This delivery order was not set aside for any particular business type.

Generated 12/18/24, 9:43 AM